Hydroxy Cerivastatin-d3 Sodium Salt

• CAT Number: R009821
• CAS Number: NA
• Molecular Formula: C₂₆H₃₀D₃FNNaO₆
• Molecular Weight: 500.55
• Purity: ≥95%
• Synonyms: (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-[(1S)-2-hydroxy-1-methylethyl]-5-[(methoxy-d3)-methyl]-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt; M-23 Metabolite-d3
• Storage: -20°C
• IUPAC Name: sodium;(E,3R,5S)-7-[4-(4-fluorophenyl)-6-[(2S)-1-hydroxypropan-2-yl]-2-propan-2-yl-5-(trideuteriomethoxymethyl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate
• InChI: InChI=1S/C26H34FNO6.Na/c1-15(2)25-21(10-9-19(30)11-20(31)12-23(32)33)24(17-5-7-18(27)8-6-17)22(14-34-4)26(28-25)16(3)13-29;/h5-10,15-16,19-20,29-31H,11-14H2,1-4H3,(H,32,33);/q;+1/p-1/b10-9+;/t16-,19-,20-;/m1./s1/i4D3
• InChIKey: KXWIMFNOEPAPDJ-KYRYBIALSA-M
• SMILES: [2H]C([2H])([2H])OCC1=C(C(=C(N=C1[C@H](C)CO)C(C)C)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F.[Na+]

Hydroxy Cerivastatin-d3 Sodium Salt is a deuterated form of hydroxy cerivastatin, where three hydrogen atoms have been replaced by deuterium. This isotopically labeled compound is utilized in pharmaceutical research to study the metabolism, pharmacokinetics, and pharmacodynamics of cerivastatin, a lipid-lowering drug. The incorporation of deuterium enhances the precision and accuracy of analytical techniques such as mass spectrometry, allowing for more reliable tracking of the compound in biological systems. Hydroxy Cerivastatin-d3 Sodium Salt is crucial for researchers focused on cardiovascular drug development, providing detailed insights into the metabolic pathways and efficacy of statins, aiding in the optimization of therapeutic strategies.